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Abstract
Background: A lack of neurotrophic support is believed to contribute to the development of diabetic neuropathy. On the other
hand, neurotrophins have consistently been shown to increase in the central and peripheral nervous system following exercise, but
the effects of exercise intervention on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in diabetic neuropa-
thy are not understood.
Objectives: This experimental study was designed and carried out at the Tarbiat Modares university (TMU) in Tehran, Iran, to investi-
gate the hypothesis that increased activity as endurance training can help to increase the endogenous expression of neurotrophins
in diabetic rats.
Methods: This was an experimental study with 2× 2 factorial plans performed at TMU in Iran. Sampling was accidental and 28 adult
male Wistar rats in the body mass range of 326.3 ± 8.4 g comprised the sample, with each rat randomly assigned to four groups:
diabetic control (DC), diabetic training (DT), healthy control (HC), and healthy training (HT). To induce diabetic neuropathy, after
12 hours of food deprivation, an intraperitoneal injection of streptozotocin (STZ) solution (45 mg/Kg) method was used. Two weeks
after STZ injection, the endurance training protocol was performed for 6 weeks; 24 hours after the last training session, the rats were
sacrificed. Real-time PCR was used for BDNF and NGF expression.
Results: The data indicate that diabetes decreases BDNF and NGF expression in sensory (92%, P = 0.01; 90%, P = 0.038, respectively) and
motor (93%, P = 0.05; 60%, P = 0.029, respectively) roots. However, NGF mRNA levels in the DT group were significantly higher than
in the HC group ((7.1-fold), P = 0.01; (2.2-fold), P = 0.001, respectively, for sensory and motor roots), but this was not shown for BDNF.
In addition, endurance training can increase NGF expression in healthy rats ((7.4-fold), P = 0.01; (3.8-fold), P = 0.001, respectively, for
sensory and motor roots).
Conclusions: This study shows that BDNF and NGF expression decreases in diabetic neuropathy. However, this decrease can be
reversed through endurance training. These results also indicate that endurance training may have a potential role in compensating
for neurotrophin deficiency following diabetic neuropathy.
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1. Background
Diabetic neuropathy is a descriptive term that includes
a spectrum of clinical syndromes and their subsets and
also includes peripheral nerve dysfunction in patients
with diabetes mellitus after excluding other causes of neu-
ropathy (1). This disease features structural changes in the
peripheral nerves, including axonal atrophy, demyelina-
tion, the loss of nerve fibers, and the slow regeneration of
nerve fibers; it can also lead to symptoms such as pain and
the loss of sensation (2).
The etiology of diabetic neuropathy is unclear; how-
ever, the accumulation of the final products of glycation,
vascular dysfunction, oxidative stress, and changes in neu-
rotrophic support are considered important factors in the
genesis of this disease (3). In diabetes, neurotrophin pro-
duction and its supportive role is reduced; hence, the lack
and deficiency of neurotrophic factors and their receptors
are involved in the progression of diabetic neuropathy,
and it can partially cause the dysfunction of axons and be
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a factor in the pathogenesis of diabetic neuropathy (4). At-
rophy and even neuron death can occur in diabetic neu-
ropathy due to the loss of growth factors (5). In differ-
ent animal studies, a decreased level of mRNA was seen in
diabetic muscle related to nerve growth factor (NGF) and
neurotrophin-3 (NT-3) (6, 7). Nevertheless, an increase in
brain-derived neurotrophic factor (BDNF) mRNA levels was
reported (6, 7). NGF is necessary for the growth and mainte-
nance of neuron phenotypes in the peripheral nervous sys-
tem and for the functional integrity of the cholinergic neu-
rons in the central nervous system (8). NGF applies its ef-
fects through retrograde transport with tyrosine kinase A
(TrkA), a high-affinity receptor, and p75, a low affinity recep-
tor (9). Hence, peripheral neuropathies can be associated
with a lack of regulation in either the synthesis, transport,
or use of NGF in PNS neurons (8). NGF administration in
animal models with diabetic neuropathy has protective ef-
fects on the neurons of the peripheral nervous system, and
it alleviates their neuropathic symptoms, but the use of
exogenous NGF (originating outside the body) has side ef-
fects such as muscle pain and hyperalgesia (increased pain
sensitivity) (8) and also carries some restrictions on its ex-
ogenous use (10). BDNF, as another member of the neu-
rotrophin family, is also involved in the neuroplasticity, dif-
ferentiation, and survival of the central nervous system. It
has also been shown that the reduction of BDNF serum lev-
els as a result of diabetes is associated with cognitive dis-
orders (11). Thus, it seems important to consider this neu-
rotrophin. Although many studies have shown that BDNF
can promote the regeneration of axons and the reconnec-
tion of injured nerve fibers, it also has limitations. The neu-
rotrophin has varying effects on neuronal populations (12),
and the fact that there are adverse effects related to the op-
timal health function of BDNF is a challenge in its medi-
cal use (13, 14). It also modifies the expression of impor-
tant molecules such as synapsin, which is very important
for synaptic transmission.
Much of what is currently known about the trophic
support has been understood through the exogenous use
of neurotrophin proteins. Although they have potential
impacts on the characteristics of motor neurons (15) and
muscle (16), whether the neurotrophins used as exogenous
are placed at the good physiological range of expressing
these proteins or not, is unclear. Therefore, a model that
raises endogenous neurotrophins may provide a good un-
derstanding of their function in the nervous system. As
in this way, the possibility to express the neurotrophin in
their physiological location is more than their exogenous
(17, 18). Exercise training is a model that can affect neu-
rotrophin expression in the proper physiological range.
The increased activity of exercise training increases the re-
generation of sensory neurons and gene expression that
stimulates the proteins required for growth and for the
regeneration of axons (19) after injury. Previous studies
have shown that increased physical activity can increase
the trophic support in the peripheral nerves and their tar-
get tissues. For example, a huge increase in BDNF expres-
sion throughout the nervous system has frequently been
seen in animals, according to the mileage covered, follow-
ing wheel running (20, 21). Several studies have also shown
that NGF in various segments of the nervous and muscular
system increases as a result of exercise training (9, 22).
Thus, we expect that the expression of BDNF and NGF
will be regulated positively with increased mobility and
physical activity and will be regulated negatively with the
induction of diabetes. The present study examines the hy-
pothesis that the increased activity of endurance training
can help to increase the endogenous expression of neu-
rotrophins in diabetic rats.
2. Objectives
The aim of this study is to investigate the effects of in-
creased activity as endurance training on the gene expres-
sion of neurotrophins (BDNF, NGF) at the sensory and mo-
tor roots of the sciatic nerve in diabetic rats.
3. Methods
3.1. Experimental Design
This study was designed and carried out at the Tar-
biat Modares university (TMU) in Tehran, Iran (2013). In
this experimental study, 28 male Wistar rats were ran-
domly divided (simple randomization) into four groups
(with seven rats in each group). One of these groups was
randomly selected as the control (healthy control (HC)),
and one of other groups was randomly selected as healthy
training (HT). Type 2 diabetes mellitus was induced in the
other two groups with the administration of 45 mg/kg of
body weight streptozotocin (STZ) dissolved in fresh citrate
buffer. One of the diabetic rat groups was selected ran-
domly as the diabetic control (DC), and the other group’s
rats were treated with endurance training (diabetic train-
ing (DT)). Throughout the treatment period, the rats were
maintained in single cages. The studied groups were as fol-
lows:
- Group 1: diabetic control rats (HT): received water and
feed.
- Group 2: diabetic training (HT): received water and
feed and performed resistance training for six weeks.
- Group 3: diabetic control rats (DC): received water and
feed.
- Group 4: diabetic training (DT): received water and
feed and performed resistance training for six weeks.
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3.2. Animals andMaintenance Conditions
Twenty-eight Wistar rats (200 - 250 g, 10 mo), were
purchased from Pasture institute (Tehran, Iran) and main-
tained in the animal house, School of Medical Sciences
of Tarbiat Modares University (TMU). All the animals were
maintained in controlled environmental conditions with
an average temperature of 22± 3°C, a light-dark cycle of 12:
12 hours, and the free access to specific foods and water. Af-
ter two weeks of familiarization and adjustment of the an-
imals to the new environment and achieving the optimal
weight of 326.3±8.4 g (23), the rats were randomly divided
into four groups of seven: healthy control (HC), healthy
training (HT), diabetes control (DC), and diabetes training
(DT). During the familiarization, in order to adapt to the
laboratory conditions, treadmills, and manipulation, the
animals walked on a treadmill at a speed of 10 meters per
minute for 10 - 15 minutes, 5 days per week. All experi-
ments were performed in accordance with the guide for
the care and use of laboratory animals (national institutes
of health publication No. 85-23, revised 1985) and were ap-
proved by the research and ethics committee of Tarbiat
Modares University (TMU). The committee’s guidelines for
care and use of laboratory animals were also followed.
3.3. Induction of Diabetes by STZ
Diabetes was induced in the appropriate rats after 12
hours of food deprivation, with an intraperitoneal injec-
tion of STZ solution (Sigma, St. Louis, MO; 45 mg / Kg dis-
solved in fresh citrate buffer 0.5 mol/L, PH: 4.5). The non-
diabetic rats were also injected with an equivalent volume
of citrate buffer. Forty-eight hours after injection, with a
small injury by lancet on the tail vein of the rats, a drop
of blood was placed on a glucometer strip, and the strip
was read by a glucometer (Glucotrend 2, Roche company
of Germany). The rats with blood glucose greater than 300
mg/dL entered the present study as the diabetic rats (23).
It should be noted that in this study, after the injection of
STZ, no symptoms caused by wrong injection, such as ab-
dominal swelling or digestive problems, were observed in
the animals. Two weeks after the induction of diabetes, the
endurance training protocol was carried out for six weeks.
Then all training sessions were held at the end of the sleep
cycle of the animals between the hours 4:00 - 6:00 p.m.
3.4. Training Program
The present study used a moderate training intensity
(55% - 50% of maximal oxygen consumption), yet one that
was efficient in terms of physiology (9). The training
groups were exposed to the treadmill training at moder-
ate intensity for six weeks for five days per week. The speed
and duration of the treadmill training gradually rose and
increased at the following rate:
- 10 meters per minute for 10 minutes in the first week;
- 10 meters per minute for 20 minutes in the second
week;
- 14 - 15 meters per minute for 20 minutes in the third
week;
- 14 - 15 meters per minute for 30 minutes in the fourth
week; and
- 17 - 18 meters per minute for 30 minutes in the fifth
week.
In order to achieve a steady state in produced adapta-
tions, all training variables were kept constant at the end
of training (9). Training shock was used during the en-
durance training program, and if necessary, the animals
were forced to continue training using the hand or sound
stimulus on the cover of the treadmill.
3.5. Behavioral Tests for Mechanical Allodynia and Thermal Hy-
peralgesia
Thermal hyperalgesia was measured using the method
of Hargreaves and et al., with little change (24). In other
words, using a radiant heat plantar test (Ugo Bassil, Italy),
the animals were placed in a Plexiglas chamber (22 cm
length× 22 cm width and 13.3 cm height) on a clean Plex-
iglas sheet. After 30 minutes of the animal’s adaptation
to the new environment, the middle segment of the ani-
mal’s paw was exposed to constant thermal radiation with
the displacement of the moving source of thermal radia-
tion. After the thermal radiation, the timer was activated,
and by foot dragging, the light was cut off and the timer
stopped. By recording the paw withdrawal latency (PWL),
the damage tolerance to thermal stimuli was measured.
Each paw was tested alternately, three times at intervals of
5 to 10 minutes, and the average of the measurements was
recorded as the thermal pain threshold. Also, to prevent
tissue damage, the test cutoff was considered to be 22 sec-
onds. Finally, the thermal hyperalgesia was calculated as
the percent of maximum possible effects, using the follow-
ing formula:
%MPE = ((base delay -delay after Streptomycin injec-
tion)× 100)/ (base delay-time cut off))
In addition, the average of three initial measurements
was considered as a base delay.
In order to measure the mechanical allodynia, the an-
imals were also put on a wired network inside a Plexiglas
chamber with dimensions of 20 × 20 cm and a height of
30 cm. To allow the animals get used to the new environ-
ment, they were put inside the transparent chamber on the
mesh 30 minutes before the test. To assess the mechanical
allodynia, various Von Frey fibers in the range of 2 g to 60
g (2, 4, 6, 8, 15, 26, 60), made by the Stolting company, USA,
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were used to measure the sensitivity of the skin to contact
stimulation. Each test began with the lowest weight, and in
cases where no response was recorded, fibers with a higher
weight were used. If two consecutive responses (lifting the
leg by the animal) were observed, the same weight was con-
sidered as the paw withdrawal threshold (PWT), and the
test did not continue. If the animal did not respond to any
of the fibers, including the fiber number 60, that fiber was
considered as a threshold response. Each experiment was
repeated three times at a frequency of at least three min-
utes, and the mean was calculated as the paw withdrawal
threshold (25). In general, the measurement of mechanical
allodynia and thermal hyperalgesia was performed both
before the STZ injection and 14 days after the injection.
3.6. Fasting Blood Glucose
The initial and final fasting blood glucose (FBG) levels
of all groups were recorded after six weeks. Then in a fast-
ing condition, the animals were anesthetized by using ke-
tamine (75 mg/kg bw) and xylazine (10 mg/kg bw) IP. The
blood samples were collected by cardiac puncture, and the
serum was separated immediately. FBG was measured en-
zymatically using commercial kits (Pars Azemoon, Tehran,
Iran) with the aid of a spectrophotometer (JENWAY 6505
European Union).
3.7. Tissue Extraction
At the end of the six-weeks of training program, 12
hours after the last training session and after the anestheti-
zation, the sensory and motor segment of spinal segments
L4, L5, and L6 were isolated under sterile conditions. The
desired tissue was immediately frozen in liquid nitrogen,
and the sample was kept at 80°C until the molecular anal-
ysis was performed.
3.8. RNA Extraction and cDNA Synthesis
Approximately 50 mg of spinal cord tissue was sepa-
rately homogenized in QIAzol Lysis reagent for a total RNA
extraction at a ratio of 1 to 10. To remove the protein com-
ponents, the obtained product was centrifuged at 4°C, 10
minutes, 12,000 g. Then it was mixed with chloroform at
a ratio 1 to 0.5 and was severely shaken for 15 seconds. The
product was centrifuged at 4°C, 15 minutes, 12,000 g, and
the mineral and water components were separated. After
that, the RNA content was removed and mixed with iso-
propanol at a ratio of 1 to 0.5 and was centrifuged for 10
minutes at room temperature and then at 4°C, 10 minutes,
12,000 g. A pellet containing RNA was rinsed in ethanol and
dissolved in 20 µL of RNAS-free water. The RNA concentra-
tion was measured (Eppendorff, Germany), and the ratio of
260 to 280 was defined as the optimal purification between
1.8 and 2. CDNA was synthesized by using 1 µg of RNA, ran-
dom hexamer primer, and the M-Mulv Reverse Transcrip-
tase enzyme (PrimeScript RT Reagent Kit, Takara). All the
processes of cDNA synthesis were executed according to kit
protocol and company manuals.
3.9. Real-Time PCR
The expression levels of mRNA NGF and BDNF were
measured using the quantitative method of Real-Time PCR
and Premix SYBR Green II (USA Applied Biosystems). The re-
action of the mixture was performed in a final volume of
20µL, each reaction performed in duplicate. Primers were
designed based on information from the NGF, BDNF, and
GAPDH genes from NBCI GenBank (Macrogen Inc., Seoul,
Korea). The sequences of the primers used are reported in
Table 1 (GAPDH was used as a control gene). The tempera-
ture used for Real-Time PCR was 95 for 10 minutes, 95 for 15
seconds, 60 for 1 minute (repeat of 40 cycles). The expres-
sion of the desired genes was measured by the 2 -∆∆CT
method. All the instruments used were calibrated via stan-
dard protocols, and all gene expression processes were per-
formed in the genetics laboratory of Tarbiat Modares uni-
versity.
Table 1. The Sequences of Primers Used in the Present Study
Primer Sequence GenBank
BDNF NM_012513.3
For: 5′ - CGACGTCCCTGGCTGACACTTTT -3′
Rev: 5′ - GTAAGGGCCCGAACATACGATTGG-3′
NGF NM_001277055.1
For: 5′ - CAC CTC TTC GGA CAC TCT GGA -3′
Rev: 5′ - CGT GGC TGT GGT CTT ATC TCC -3′
GAPDH NM_017008
For: 5′ - GACATGCCGCCTGGAGAAAC -3′
Rev: 5′ - AGCCCAGGATGCCCTTTAGT -3′
3.10. Statistical Analysis
All the data have been described based on the average
± standard deviation. The Kolmogorov-Smirnov test was
used to determine the normality of the data distribution,
and Levene’s test was used to measure the equality of vari-
ances. All data were normal, and given that the present
study was a 2 × 2 factorial plan, the two-way ANOVA test
and post hoc LSD test were used to determine the signif-
icant differences between groups and the interaction of
the variables. We also used a repeated measures test to
analyze the simultaneous effects of time and groups on
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blood glucose and body mass, because these variables were
measured twice (pre and post). The significance level was
considered P≥ 0.05. All the statistical analyses were per-
formed using SPSS version 20.
4. Results
4.1. Body Mass
The results related to changes in body mass over six
weeks for each group are shown in Figure 1. The results
show that six weeks of diabetes caused more significant
weight loss in this group than the pre-test (P < 0.01), indi-
cating that atrophy was caused by diabetes. There is also a
significant difference between DT and DC (P < 0.01) and be-
tween HC and HT (P < 0.01), indicating that although the
endurance training could reduce weight loss due to dia-
betes, it failed to fully compensate for it.
Figure 1. Changes in body mass in different groups.
0
50
100
150
200
250
300
350
400
450
DC DT HC HT
B
od
y 
M
as
s,
 g
Pre-Training
Post-Training#*
* Significant difference with healthy untrained group (P < 0.01), # significant dif-
ference with normal trained group (P < 0.01), † significant difference with diabetes
untrained group (P < 0.01).
4.2. Blood Glucose
The data on blood glucose before and after the test in
the four groups shows that at the beginning of the train-
ing program, the DC glucose concentration was signifi-
cantly higher than that of the healthy groups (P = 0.0001)
and that it still showed a significant difference after six
weeks of endurance training (P = 0.0001). At the end of the
training program, the DT glucose concentration was signif-
icantly lower than the DC (P = 0.0001), indicating that six
weeks of endurance training could reduce the blood glu-
cose in diabetic rats (Table 2).
Figure 2. Changes in plasma glucose levels in different groups.
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4.3. Sensitivity to Mechanical and Thermal Stimulation
The average latency of the paw withdrawal test in hy-
peralgesia heat and the changes in the paw withdrawal
threshold in the mechanical allodynia test (Table 3) before
starting the training program (two weeks after the dia-
betes induction) in the diabetic groups was significantly
lower than that in the healthy groups P≥ 0.0001).
4.4. Gene Expression Levels of BDNF and NGF in Sensory Seg-
ment of Spine
Results of a two-way ANOVA test showed that there was
a significant difference between the healthy control group
and the diabetes control group for BDNF mRNA (P = 0.01).
This means that diabetes significantly decreased the BDNF
gene expression in the sensory roots of the sciatic nerve (-
0.94-fold). Moreover, no significant difference was seen be-
tween the healthy control group and the healthy trained
group. In other words, the endurance training did not
cause changes in the gene expression of BDNF (P = 0.464)
(0.50-fold), although the healthy trained group showed a
tendency of a nonsignificant decrease. Nonetheless, the
results showed that there was no significant difference
between the values of BDNF mRNA between the diabetic
trained group and the healthy control group (P = 0.07) (-
0.64-fold). In other words, six-week endurance training
could compensate for the reduction of BDNF expression
caused by diabetes (0.30-fold); however, its absolute values
were still lower than those of the healthy control group (Ta-
ble 4).
Also, NGF mRNA levels in the DC group were signifi-
cantly lower than in the HC group (P = 0.038) (-0.90-fold).
In contrast to BDNF, the endurance training significantly
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Table 2. Changes in Body Mass and Blood Glucose in Different Groupsa
Groups Fasting Blood Glucose,mg/dL BodyMass, g
Week 0 Week 6 Week 0 Week 6
Healthy control (HC) 99.71± 91 105.4± 12 318.23± 17 382.14± 24
Healthy training (HT) 100.2± 13 92.85± 73 353.69± 23 322.57± 28b
Diabetic control (DC) 356.71± 35 511.85± 25b 330.28± 40 302.85± 25c
Diabetic training(DT) 354.74± 38 457.42± 27b , d 334.28± 33 353.69± 27d
aEach value is the mean± SD of the seven rats in each group.
bBody mass, in comparison with healthy control rats (P < 0.01); FBS, in comparison with healthy control rats (P = 0.0001).
cBody mass, diabetic control group, was compared before and after 6 weeks (P < 0.01); FBS, diabetic control group compared with all other groups after day 42 (P =
0.0001).
dBody mass, in comparison with healthy control rats (P < 0.01); FBS, in comparison with healthy control rats (P = 0.0001).
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Figure 3. Changes in A, latency of paw withdrawal in thermal hyperalgesia test (seconds); and B, paw withdrawal threshold in mechanical allodynia test (grams) in different
groups. * Significant difference with healthy control group (P < 0.001), # significant difference with healthy trained group (P < 0.001).
increased the NGF mRNA in the healthy trained group com-
pared with those of the HC group (P = 0.01) (7.4-fold). The
NGF mRNA levels in the DT group were significantly higher
than those in the HC group (p = 0.01) (2.2-fold change). Al-
though the NGF mRNA level in HT was higher than in DT,
this difference was not significant (P = 0.73), (1.6-fold), (Ta-
ble 4).
4.5. Gene Expression Levels of BDNF and NGF in Spinal Motor
Segment
The results showed a significant difference for BDNF
mRNA between the healthy control group and the diabetic
control group (P = 0.05) (-0.90-fold). In other words, di-
abetes significantly decreased the BDNF gene expression
in the motor roots of the sciatic nerve. Nor did the en-
durance training alone cause changes in the gene expres-
sion of BDNF (P = 0.299) (-0.63-fold). Nevertheless, these
results suggest that the BDNF mRNA levels in the diabetic
trained group were higher than those in the diabetic con-
trol group (0.35-fold) but that they were significantly lower
compared to the healthy control group (P = 0.01) (-0.65-
fold). In other words, six weeks of training could compen-
sate for the reduction of BDNF expression caused by dia-
betes but could not return it to its original level (Table 4).
In this regard, the NGF mRNA levels in the DC group
were significantly lower than in the HC group (P = 0.029)
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Figure 4. The Values of Gene Expression
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Table 3. Changes in Latency of Paw Withdrawal in Thermal Hyperalgesia Test (Sec-
ond) and Paw Withdrawal Threshold in Mechanical Allodynia Test (Gram) in Differ-
ent Groupsa
Groups PawWithdrawal
Latency (s)
PawWithdrawal
Threshold (g)
Healthy control (HC) 12.76± 0.22 60± 0
Healthy training
(HT)
13.2± 0.53 60± 0
Diabetic control (DC) 8.8± 0.55b , c 22± 4b , c
Diabetic training(DT) 9.1± 0.73b , c 20± 2b , c
aEach value is the mean± SD of the seven rats in each group.
bP < 0.001, in comparison with healthy control rats.
cP < 0.001, in comparison with healthy trained rats.
(-0.60-fold). Additionally, the HT group showed higher lev-
els of NGF mRNA compared to the HC group (P = 0.001) (3.8-
fold). Similar to the sensory segment, the endurance train-
ing significantly increased the NGF mRNA levels in the DT
group compared to the healthy rats (P = 0.001) (2.2-fold)
(Table 4).
5. Discussion
The aim of the present study was to investigate the ef-
fects of six weeks of endurance training on NGF and BDNF
gene expression in the sensory and motor segments of
spinal cord of rats with diabetes induced by STZ. With re-
spect to the first part, namely, the effects of diabetes on
body mass, the results showed that there was a significant
difference between the diabetic group in pre- and post-
test, while on the other hand, there was a significant dif-
ference between the healthy control group and diabetes in
the body mass (Table 2). These results suggest that diabetes
alone could reduce the weight of the animals that could be
a sign of atrophy caused by diabetes. Nonetheless, when
the values of the pre- and post-tests of the diabetic group
were compared with each other, we did not see a signifi-
cant difference between them. Thus we can conclude that
endurance training may compensate for a part of the mus-
cular atrophy caused by diabetes.
In addition, at the end of the training program, the
blood glucose concentration of the DT group was signifi-
cantly lower than that of the diabetic control group, indi-
cating that six weeks of endurance training could reduce
the plasma glucose in diabetic rats (Table 2). These results
are consistent with the results of several other studies (26,
27). There are some possible mechanisms for this reduc-
tion, such as the increase of insulin sensitivity, the increase
of glucose transporters (Glut4), and the increase of blood
flow to skeletal muscles (26, 27).
In this study, to ensure the occurrence of diabetic neu-
ropathy, the behavioral tests for mechanical allodynia and
thermal hyperalgesia were used. The results showed that
two weeks after the induction of diabetes, the sensitivity
to Von Frey tactile and thermal stimuli significantly in-
creased; these results support the occurrence of diabetic
neuropathic pain. Pain is one of the clearest signs of neu-
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Table 4. Values of Gene Expression BDNF and NGF in Sensory and Motor Root of Sciatic Nerve Spinal Segments in Different Groupsa
Groups BDNFmRNA (Relative to Control) NGFmRNA (Relative to Control)
Sensory Roots Motor Roots Sensory Roots Motor Roots
Healthy control (HC) 1± 0 1± 0 1± 0 1± 0
Healthy training (HT) 0.50± 0.18 0.37± 0.17 7.4± 31b , c 3.8± 0.29b , c
Diabetic control (DC) 0.06± 0.03b 0.1± 0.02b 0.1± 0.12b 0.4± 0.09b
Diabetic training(DT) 0.36± 0.18c 0.45± 0.18b 7.1± 0.85b , c 2.2± 0.65b , c
aEach value is the mean± SD of the seven rats in each group.
bP≤ 0.05, in comparison with healthy control rats.
cP < 0.05, in comparison with diabetic control rats.
Figure 5. The Values of Gene Expression
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ropathy characterized by features such as hyperalgesia (in-
creased response to a stimulus that is normally painful)
and allodynia (response to a stimulus that normally does
not cause pain) (28, 29), and the result is a hyperglycemia in
diabetes status (30). The results showed that BDNF and NGF
gene expression was reduced in diabetic rats compared to
the healthy rats in the sensory and motor roots of the sci-
atic nerve; this confirms the hypothesis of reduced trophic
support as one of the causes of diabetic neuropathy. BDNF
does play an important role in the regeneration of injured
peripheral axons (31), and there is some evidence that ex-
ercise increases BDNF expression in motor neurons but
not in sensory neurons following peripheral nerve injury
(32). Neurotrophins play an important role in the devel-
opment, survival, differentiation, and function of neurons.
Neurotrophins regulate the axonal and dendritic growth
of neurons and nerve regeneration in response to the in-
jury of undamaged nerve bases (33). In this regard, sev-
eral studies have revealed the role of NGF neurotrophin
in diabetic neuropathy. Findings from previous studies
have shown that diabetes is associated with the reduced
retrograde transport of NGF, less gene expression of NGF,
and the receptors p75, and TrkA (9) in target tissues. In
line with these findings, our results showed that NGF lev-
els were significantly decreased in the DC group compared
with the HC group. The role of NGF in the etiology of di-
abetic sensory neuropathy has been shown to be due to
a defect in the retrograde transport of NGF in the sciatic
nerve (34) and the intestines of diabetic rats. These stud-
ies have proven clear relationships between incomplete
NGF expression in target tissues of the lower extremities
and the retrograde transport of NGF decreased the dorsal
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root ganglion (6) and the expression of neuropeptide, cal-
citonin gene-related peptide and substance P which are the
neuronal targets for NGF in type C fibers (35). In previ-
ous studies, it has been reported that NGF is the primary
neurotrophin in the sensory nervous system, but this neu-
rotrophin is probably produced through BDNF incremen-
tal adjustment (36), stimulating the production of VEGF
(37). And since diabetes creates disorders in the nervous
system myelin (38), it indirectly has major effects on the
motor neurons.
In this study, the endurance training considerably in-
creased NGF and BDNF gene expression in both parts of the
spinal cord in the training group compared with the DC
group. Nonetheless, in relation to BDNF, six weeks of en-
durance training could not bring the values to their initial
levels; however, they could compensate for the reduced ex-
pression of BDNF caused by diabetes (Table 4). In contrast,
one of the most interesting findings of this study is the in-
cremental adjustment of NGF gene expression after train-
ing in both the sensory and motor parts of diabetic rats’
spinal cords compared with those of healthy rats (Table
4). The increased activity of endurance training can deal
with the decreased NGF caused by diabetes and can even
increase it to higher levels than those in healthy rats.
Researchers have reported that in a diabetic state, a de-
fect in the synthesis of NGF can occur due to hyperglycemia
or hypoinsulinemia or accumulated polyol. It changes in
corticosterone concentration and 1, 25-dihydroxyvitamin
D3 and antioxidant system failure. Corticosterone re-
duces NGF synthesis, whereas 1, 25-dihydroxyvitamin D3 in-
creases it (5). In relation to the mechanisms of the effects
of physical activity on the synthesis of NGF, training can
increase the expression of NGF by affecting the above is-
sues. For example, regular training can reduce the secre-
tion of glucocorticoids (9) and can also strengthen the an-
tioxidant capacity (39).
Results from previous studies have shown that BDNF
expression is rapidly affected by physical activity; its lev-
els significantly rise even after six hours of training in rats,
and this increase is associated with an increase in the prop-
agation of nerve cells and neurogenesis (40). In contrast,
in rats that did high-intensity training, an inverse relation-
ship was seen with the training intensity. The increase
of neurotrophic factors indicate that there are limitations
in neurogenesis arising from the training programs and
from moderate-intensity training. Consequently, they lead
to an increase in BDNF (41). Different studies have also
shown a direct relationship between changes in the levels
of NGF and training. For example, Chae et al. showed that
six weeks of endurance training stopped the apoptosis of
muscle cells through increased levels of NGF in the soleus
muscle of rats with diabetes induced by STZ (9). Running
on a treadmill and swimming also kept the levels of NGF in
the hippocampus significantly higher than in the control
group after four weeks of training, and it also stimulated
neurogenesis (28). It has also been shown that voluntary
training increased the TrkC and NT-3 gene and protein ex-
pression in the spinal cord and soleus muscle of healthy
adult rats (42), and the reports suggest that it also increases
the neural–muscular activity of BDNF. (43). Voluntary run-
ning on a treadmill also increases the expression of growth
factors such as NT-3, BDNF, and GAP-43 in the spinal cord of
injured rats. (44). However, Cobianchi et al. demonstrated
that aerobic exercise training reduced both the levels of
BDNF in the dorsal root ganglion and the neuropathic pain
in rats following peripheral nerve injury (45). Similarly,
Detloff et al. very recently showed that aerobic exercise can
normalize spinal levels of glial cell-derived neurotrophic
factor (GDNF), prevent excessive sprouting of pain affer-
ents, and reduce tactile allodynia in rats following spinal
cord injury (46).
Interestingly, the results showed that BDNF mRNA in
the healthy trained groups decreased compared with the
healthy control group. To interpret this contradiction with
the reports presented above on the increased regulation
of BDNF with training, the study of Gomez-Pinilla et al.
should be mentioned. (47). They illustrated that there was
an inequality between mRNA and BDNF protein in both the
spinal cord and the soleus muscle after five days of run-
ning. Moreover, BDNF protein levels in the spinal cord were
greater than mRNA levels, but this was the opposite in the
muscle (47). Therefore, we assume that as a result of en-
durance training: 1, BDNF translation capacity increased;
or 2, the retrograde transport of BDNF of skeletal muscles
increased and supplied the spinal cord needs for BDNF; or
3, there was a combination of both. In addition, in rela-
tion to the possible mechanisms of increased BDNF, we can
mention the increase of sensory input during the training
(47), the increased activity of glucocorticoids and cholin-
ergic systems (48), the increase of NGF (34), and the intra-
cellular increase of Ca+ (49). However, nonmeasurement
of BDNF protein levels can be considered a limitation and
something to be measured in later studies.
In conclusion, this study showed that diabetes reduces
the expression of BDNF and NGF in the sensory and motor
roots of the sciatic nerve. Six weeks of training was able to
compensate for the reduction of BDNF expression caused
by diabetes, but it could not return the BDNF expression
to its original level; in relation to NGF, however, endurance
training could increase its gene expression to levels higher
than the normal state. The results of this study clearly
prove the hypothesis of reduced neurotrophic support in
diabetic neuropathy. It would appear that the neurons are
biologically compatible with the increase and decrease of
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activity and that such changes could help the survival of
neurons.
5.1. Strong Points of Study
Given the considerable prevalence of diabetic neu-
ropathy and the lack of effective treatment from a neuro-
logical point of view, considering neurotrophin activation
via physical activity may lead to more suitable treatments.
To the best of our knowledge, this study is the first to eval-
uate the relationship between physical activity and neu-
rotrophin activation.
5.2. Weak Points of Study
Only gene expressions cannot demonstrate any phys-
iological alterations. In the present study, the protein
changes were not evaluated; therefore, protein measure-
ment must also be evaluated, so that it leads to more valid
conclusions.
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